Blood Glucose Lowering Medicine
An oral film-coated tablet of a new class SGLT2 inhibitor for the treatment of diabetes mellitus type 2, inhibits glucose re-absorption in the proximal renal tubules providing an insulin independent mechanism to lower blood glucose.